The GLP-1 Denial Wave: What to Do If Your Ozempic or Wegovy Was Denied
The GLP-1 Denial Wave: What to Do If Your Ozempic or Wegovy Was Denied
6 minute read
You and your doctor decided together that a GLP-1 medication was the right choice for you. Maybe it was for type 2 diabetes management. Maybe it was for weight management that your doctor documented as medically necessary. Either way, your insurance company sent back a denial, and now you are left wondering what just happened and what you can do about it.
GLP-1 denials are one of the most common drug coverage disputes in the country right now. These medications (semaglutide under the brand names Ozempic, Wegovy, and Rybelsus, along with tirzepatide under the names Mounjaro and Zepbound) have become the center of a major insurance battle. Understanding why denials happen and what moves the needle in an appeal can make a real difference.
Why GLP-1s Are Denied So Often
GLP-1 receptor agonists are expensive. Ozempic and Wegovy carry list prices of roughly $900 to $1,400 per month before rebates or discounts.¹ Insurers, particularly for weight management indications, have responded by either excluding these drugs entirely or building significant barriers to access.
The denial landscape breaks down into a few common categories.
Indication-based denials. If you are prescribed a GLP-1 for weight management (rather than for type 2 diabetes), many commercial plans and nearly all Medicare Part D plans currently exclude coverage entirely for that indication. The Treat and Reduce Obesity Act, which would require Medicare to cover anti-obesity medications, has been debated in Congress for years but has not yet passed as of this writing.² Medicaid coverage varies dramatically by state.
Prior authorization denials. Even when a plan covers GLP-1s, it almost always requires prior authorization. The criteria vary by plan but typically include documented BMI thresholds (often 30 or higher, or 27 with a weight-related comorbidity), documented failure of lifestyle interventions, and sometimes a physician attestation that the medication is being used alongside a diet and exercise program.
Step therapy denials. Some plans require you to try and fail on older, cheaper medications before they will approve a GLP-1. For diabetes management, this might mean first trying metformin. For weight management, it might mean documenting participation in a structured weight loss program.
A 2024 analysis found that GLP-1 prior authorization denial rates ranged from 25 to 50 percent depending on the insurer and the indication.³
What Insurers Are Looking For in Prior Authorization
If your initial prior authorization was denied, or if your doctor is about to submit one for the first time, knowing what the criteria typically include gives you a real advantage.
Most commercial plans that cover GLP-1s for obesity will want to see:
For diabetes indications, the bar is often lower but still includes step therapy requirements in many plans.
The key is that your doctor's documentation needs to use language that precisely matches the plan's coverage criteria. A well-intentioned letter that does not address the specific prior authorization checklist can result in a denial even when you clearly qualify.
How to Appeal a GLP-1 Denial
If you have already been denied, you have the right to appeal. Here is the sequence that tends to be most effective.
Step 1: Get the denial notice and read the stated reason. Your insurer is required to tell you exactly why your claim was denied. The denial reason is the map for your appeal. Common reasons include "not medically necessary," "coverage exclusion for weight loss drugs," "step therapy requirements not met," and "missing documentation."
Step 2: Request a peer-to-peer review. Your prescribing physician can request a direct conversation with the insurer's medical reviewer. Many GLP-1 denials reverse at this stage, particularly when a physician can explain the clinical rationale in real time.
Step 3: File a formal internal appeal. Submit a written appeal that directly addresses each stated denial reason. Include a letter of medical necessity from your doctor, your relevant lab work, your documented treatment history, and any peer-reviewed clinical guidelines supporting the use of GLP-1s for your condition. The American Diabetes Association's Standards of Medical Care and the American Gastroenterological Association's clinical practice guidelines are frequently cited in successful appeals.
Step 4: Request external review if the internal appeal fails. An independent external review organization will evaluate your case without influence from your insurer. For denials classified as experimental or not medically necessary, external review outcomes have historically favored patients at meaningful rates.⁴
What Documentation Works
In successful GLP-1 appeals, the documents that tend to make the difference are:
What This Means for You
Being denied for a GLP-1 is frustrating, but it is not the end of the road. The appeal process exists specifically for situations like this, and the documentation that wins appeals is something you and your doctor can build together.
Ellen can help you decode your denial letter and draft an appeal that speaks directly to your insurer's criteria. Start here →
Frequently Asked Questions
Does Medicare cover Ozempic or Wegovy?
Medicare Part D covers Ozempic and Rybelsus when prescribed for type 2 diabetes. Wegovy, when prescribed specifically for weight management, is generally not covered under current Medicare rules. Zepbound for weight management also faces similar Medicare coverage limitations. Coverage under Medicare Advantage plans varies.
What if my employer plan excludes GLP-1s entirely?
If your plan has a categorical exclusion for anti-obesity medications, you have fewer appeal options because exclusions are coverage decisions rather than medical necessity decisions. You can still request an exception if you can show the medication is being used for a covered condition (such as type 2 diabetes). A benefits advocate or your state insurance commissioner may be able to help you understand your options.
How long does a GLP-1 appeal usually take?
Standard appeals typically take 30 days for a decision. Urgent appeals, where your doctor certifies that a delay would seriously jeopardize your health, must be decided within 72 hours. External reviews generally take 45 days but can be expedited in urgent circumstances.
Sources: